These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18200823)

  • 1. Secular trends in lipid-lowering treatment and lipid levels after a first acute myocardial infarction.
    Björck L; Welin C; Rosengren A
    Vasc Health Risk Manag; 2007; 3(6):1045-51. PubMed ID: 18200823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up.
    Langsted A; Freiberg JJ; Tybjaerg-Hansen A; Schnohr P; Jensen GB; Nordestgaard BG
    J Intern Med; 2011 Jul; 270(1):65-75. PubMed ID: 21198993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High lipid levels and coronary disease in women in Göteborg--outcome and secular trends: a prospective 19 year follow-up in the BEDA*study.
    Johansson S; Wilhelmsen L; Lappas G; Rosengren A
    Eur Heart J; 2003 Apr; 24(8):704-16. PubMed ID: 12713765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in serum lipids after acute coronary syndromes: secondary analysis of SPACE ROCKET study data and a comparative literature review.
    Barth JH; Jackson BM; Farrin AJ; Efthymiou M; Worthy G; Copeland J; Bailey KM; Romaine SP; Balmforth AJ; McCormack T; Whitehead A; Flather MD; Nixon J; Hall AS;
    Clin Chem; 2010 Oct; 56(10):1592-8. PubMed ID: 20729301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross sectional survey of effectiveness of lipid lowering drugs in reducing serum cholesterol concentration in patients in 17 general practices.
    Hippisley-Cox J; Cater R; Pringle M; Coupland C
    BMJ; 2003 Mar; 326(7391):689. PubMed ID: 12663406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cholesterol and long-term prognosis in middle-aged men with myocardial infarction and angina pectoris. A 16-year follow-up of the Primary Prevention Study in Göteborg, Sweden.
    Rosengren A; Hagman M; Wedel H; Wilhelmsen L
    Eur Heart J; 1997 May; 18(5):754-61. PubMed ID: 9152645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S).
    Pyŏrälä K; Pedersen TR; Kjekshus J; Faergeman O; Olsson AG; Thorgeirsson G
    Diabetes Care; 1997 Apr; 20(4):614-20. PubMed ID: 9096989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin compared to fluvastatin in the reduction of serum lipids and apolipoproteins in patients with ischaemic heart disease and moderate hypercholesterolaemia.
    Sigurdsson G; Haraldsdottir SO; Melberg TH; Tikkanen MJ; Miettinen TE; Kristianson KJ
    Acta Cardiol; 1998; 53(1):7-14. PubMed ID: 9638964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target-attainment rates of low-density lipoprotein cholesterol using lipid-lowering drugs one year after acute myocardial infarction in sweden.
    Hambraeus K; Lindhagen L; Tydén P; Lindahl B; Lagerqvist B
    Am J Cardiol; 2014 Jan; 113(1):17-22. PubMed ID: 24169006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group.
    MacMahon S; Sharpe N; Gamble G; Hart H; Scott J; Simes J; White H
    Circulation; 1998 May; 97(18):1784-90. PubMed ID: 9603532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
    Sever PS; Dahlöf B; Poulter NR; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J;
    Drugs; 2004; 64 Suppl 2():43-60. PubMed ID: 15765890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
    Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-lowering therapy and cholesterol levels following acute myocardial infarction: a German study of 5361 patients.
    Bergmann A; Schulze J; Hübner D; Weizel A; Julius U; Kreuzer J
    Eur J Epidemiol; 2003; 18(5):407-11. PubMed ID: 12889686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in lipid profiles and treatment utilization among young adults with acute myocardial infarction: Results from the VIRGO study.
    Lu Y; Zhou S; Dreyer RP; Caulfield M; Spatz ES; Geda M; Lorenze NP; Herbert P; D'Onofrio G; Jackson EA; Lichtman JH; Bueno H; Spertus JA; Krumholz HM
    Am Heart J; 2017 Jan; 183():74-84. PubMed ID: 27979045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of new atherothrombotic brain infarction in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol >or=125 mg/dl treated with statins versus no lipid-lowering drug.
    Aronow WS; Ahn C; Gutstein H
    J Gerontol A Biol Sci Med Sci; 2002 May; 57(5):M333-5. PubMed ID: 11983729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.
    Wilhelmsen L; Pyörälä K; Wedel H; Cook T; Pedersen T; Kjekshus J
    Eur Heart J; 2001 Jul; 22(13):1119-27. PubMed ID: 11428852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between lipid testing and statin therapy in acute myocardial infarction patients.
    Ko DT; Alter DA; Newman AM; Donovan LR; Tu JV
    Am Heart J; 2005 Sep; 150(3):419-25. PubMed ID: 16169318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S).
    Kjekshus J; Pedersen TR
    Am J Cardiol; 1995 Sep; 76(9):64C-68C. PubMed ID: 7572690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum total, LDL, HDL cholesterol and triglycerides related to age, gender and cigarette smoking in patients with first acute myocardial infarction.
    Vincelj J; Sucić M; Bergovec M; Sokol I; Mirat J; Romić Z; Lajtman Z; Bergman-Marković B; Bozikov V
    Coll Antropol; 1997 Dec; 21(2):517-24. PubMed ID: 9439068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in physician compliance with guideline on lipid profile determination within 24 h after acute myocardial infarction.
    Al Aqeel A; Mojiminiyi OA; Al Dashti R; Al Ozairi ES
    Med Princ Pract; 2005; 14(1):41-5. PubMed ID: 15608480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.